3.57 USD
+0.28 (+8.51%)
We assign a fundamental rating of 3 out of 10 to PETS. PETS was compared to 122 industry peers in the Specialty Retail industry. PETS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. PETS does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year PETS has reported negative net income.
PETS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: PETS reported negative net income in multiple years.
PETS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of -4.22%, PETS is not doing good in the industry: 67.21% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -7.37%, PETS is in line with its industry, outperforming 45.90% of the companies in the same industry.
PETS has a Return On Invested Capital of 0.49%. This is comparable to the rest of the industry: PETS outperforms 40.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.22% | ||
| ROE | -7.37% | ||
| ROIC | 0.49% |
ROA(3y)-2.83%
ROA(5y)3.96%
ROE(3y)-4.97%
ROE(5y)4.31%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Operating Margin of PETS (0.24%) is worse than 60.66% of its industry peers.
PETS has a worse Gross Margin (30.46%) than 66.39% of its industry peers.
PETS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.24% | ||
| PM (TTM) | N/A | ||
| GM | 30.46% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.16%
GM growth 5Y1.28%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PETS is destroying value.
PETS has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, PETS has more shares outstanding
PETS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 2.95 indicates that PETS is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.95, PETS is doing good in the industry, outperforming 68.85% of the companies in the same industry.
PETS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.95 |
ROIC/WACC0.05
WACC9.67%
2.3 Liquidity
A Current Ratio of 1.26 indicates that PETS should not have too much problems paying its short term obligations.
With a Current ratio value of 1.26, PETS perfoms like the industry average, outperforming 45.90% of the companies in the same industry.
A Quick Ratio of 1.00 indicates that PETS may have some problems paying its short term obligations.
PETS has a Quick ratio of 1.00. This is in the better half of the industry: PETS outperforms 72.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
PETS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.00%, which is quite impressive.
PETS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -19.24%.
PETS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.39% yearly.
EPS 1Y (TTM)22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-125.68%
Revenue 1Y (TTM)-19.24%
Revenue growth 3Y-6.02%
Revenue growth 5Y-4.39%
Sales Q2Q%-30.13%
3.2 Future
Based on estimates for the next years, PETS will show a very strong growth in Earnings Per Share. The EPS will grow by 27.38% on average per year.
PETS is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -3.12% yearly.
EPS Next Y26.23%
EPS Next 2Y42.6%
EPS Next 3Y27.38%
EPS Next 5YN/A
Revenue Next Year-14.05%
Revenue Next 2Y-5.92%
Revenue Next 3Y-3.12%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
PETS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PETS. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PETS is valued cheaper than 97.54% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 1.91 |
4.3 Compensation for Growth
PETS's earnings are expected to grow with 27.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.6%
EPS Next 3Y27.38%
5. Dividend
5.1 Amount
No dividends for PETS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:PETS (1/6/2026, 8:00:01 PM)
3.57
+0.28 (+8.51%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners36.25%
Inst Owner Change0%
Ins Owners5.27%
Ins Owner Change6.21%
Market Cap75.04M
Revenue(TTM)226.97M
Net Income(TTM)-6.27M
Analysts40
Price Target2.81 (-21.29%)
Short Float %18.81%
Short Ratio0.84
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0.01
Dividend Growth(5Y)-61.77%
DP-2.89%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-808.7%
Min EPS beat(2)-1129.17%
Max EPS beat(2)-488.23%
EPS beat(4)2
Avg EPS beat(4)-256.31%
Min EPS beat(4)-1129.17%
Max EPS beat(4)296.08%
EPS beat(8)3
Avg EPS beat(8)-276.16%
EPS beat(12)3
Avg EPS beat(12)-223.62%
EPS beat(16)4
Avg EPS beat(16)-171.34%
Revenue beat(2)0
Avg Revenue beat(2)-14.24%
Min Revenue beat(2)-15.64%
Max Revenue beat(2)-12.84%
Revenue beat(4)0
Avg Revenue beat(4)-12.79%
Min Revenue beat(4)-15.64%
Max Revenue beat(4)-11.17%
Revenue beat(8)1
Avg Revenue beat(8)-8.02%
Revenue beat(12)1
Avg Revenue beat(12)-7.7%
Revenue beat(16)1
Avg Revenue beat(16)-7.62%
PT rev (1m)0%
PT rev (3m)-8.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-16.67%
EPS NY rev (1m)0%
EPS NY rev (3m)-83.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.94%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.33 | ||
| P/FCF | N/A | ||
| P/OCF | 15.91 | ||
| P/B | 0.88 | ||
| P/tB | 1.66 | ||
| EV/EBITDA | 1.91 |
EPS(TTM)-0.3
EYN/A
EPS(NY)-0.22
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)0.22
OCFY6.29%
SpS10.8
BVpS4.05
TBVpS2.15
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.22% | ||
| ROE | -7.37% | ||
| ROCE | 0.63% | ||
| ROIC | 0.49% | ||
| ROICexc | 1.36% | ||
| ROICexgc | N/A | ||
| OM | 0.24% | ||
| PM (TTM) | N/A | ||
| GM | 30.46% | ||
| FCFM | N/A |
ROA(3y)-2.83%
ROA(5y)3.96%
ROE(3y)-4.97%
ROE(5y)4.31%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.16%
GM growth 5Y1.28%
F-Score5
Asset Turnover1.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 72.64% | ||
| Cap/Sales | 2.25% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 62.27% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 2.95 |
F-Score5
WACC9.67%
ROIC/WACC0.05
Cap/Depr(3y)94.91%
Cap/Depr(5y)89.72%
Cap/Sales(3y)1.98%
Cap/Sales(5y)1.47%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-125.68%
EPS Next Y26.23%
EPS Next 2Y42.6%
EPS Next 3Y27.38%
EPS Next 5YN/A
Revenue 1Y (TTM)-19.24%
Revenue growth 3Y-6.02%
Revenue growth 5Y-4.39%
Sales Q2Q%-30.13%
Revenue Next Year-14.05%
Revenue Next 2Y-5.92%
Revenue Next 3Y-3.12%
Revenue Next 5YN/A
EBIT growth 1Y105.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year55.61%
EBIT Next 3Y48.58%
EBIT Next 5YN/A
FCF growth 1Y-103.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.29%
OCF growth 3Y-36.58%
OCF growth 5Y-34.4%
PETMED EXPRESS INC / PETS FAQ
What is the ChartMill fundamental rating of PETMED EXPRESS INC (PETS) stock?
ChartMill assigns a fundamental rating of 3 / 10 to PETS.
What is the valuation status for PETS stock?
ChartMill assigns a valuation rating of 1 / 10 to PETMED EXPRESS INC (PETS). This can be considered as Overvalued.
What is the profitability of PETS stock?
PETMED EXPRESS INC (PETS) has a profitability rating of 2 / 10.
Can you provide the dividend sustainability for PETS stock?
The dividend rating of PETMED EXPRESS INC (PETS) is 0 / 10 and the dividend payout ratio is -2.89%.